(Q38279726)

1 September 2017

1 reference

title

Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria (English)

1 reference

1 September 2017

main subject

multiple drug resistance

1 reference

3

Petra Gastmeier

1 reference

1 September 2017

1

Markus Ruhnke

1 reference

1 September 2017

Renate Arnold

2

1 reference

1 September 2017

publication date

24 November 2014

1 reference

Lancet Oncology Commission

1 September 2017

published in

1 reference

1 September 2017

volume

15

1 reference

1 September 2017

issue

13

1 reference

1 September 2017

page(s)

e606-19

1 reference

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Bacteraemia in febrile neutropenic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Matrix-assisted laser desorption ionization-time of flight (maldi-tof) mass spectrometry for detection of antibiotic resistance mechanisms: from research to routine diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

The new beta-lactamases.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Antibiotics as selectors and accelerators of diversity in the mechanisms of resistance: from the resistome to genetic plasticity in the β-lactamases world

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Bad bugs, no drugs: no ESCAPE revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Infection-control interventions for cancer patients after chemotherapy: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Implementing strategic bundles for infection prevention and management

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

The intestinal microbiota and susceptibility to infection in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Significant reduction in vancomycin-resistant enterococcus colonization and bacteraemia after introduction of a bleach-based cleaning-disinfection programme

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Methicillin-resistant Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

High incidence of methicillin-resistant Staphylococcus aureus sepsis and death in patients with febrile neutropenia at Royal Darwin Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Clinical impact of MRSA in a stem cell transplant unit: analysis before, during and after an MRSA outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Prevention and control of methicillin-resistant Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Review of a major epidemic of methicillin-resistant Staphylococcus aureus: the costs of screening and consequences of outbreak management

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Discontinuation of contact precautions for methicillin-resistant staphylococcus aureus: a randomized controlled trial comparing passive and active screening with culture and polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

The national one week prevalence audit of universal meticillin-resistant Staphylococcus aureus (MRSA) admission screening 2012.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Risk factors associated with the community-acquired colonization of extended-spectrum beta-lactamase (ESBL) positive Escherichia Coli. an exploratory case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Pet animals and foreign travel are risk factors for colonisation with extended-spectrum β-lactamase-producing Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Extended-spectrum β-lactamase-producing enterobacteriaceae among travelers from the Netherlands.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Extended-spectrum β-lactamase-producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Outbreak caused by tobramycin-resistant Pseudomonas aeruginosa in a bone marrow transplantation unit

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Outbreak of multi-drug resistant Pseudomonas aeruginosa bloodstream infection in the haematology unit of a South African Academic Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Acinetobacter baumannii: an emerging opportunistic pathogen

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Factors influencing the early mortality in haematological malignancy patients with nosocomial Gram negative bacilli bacteraemia: a retrospective analysis of 154 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Audit of fluoroquinolone prophylaxis against chemotherapy-induced febrile neutropenia in a hospital with highly prevalent fluoroquinolone resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Prevention of febrile neutropenia: use of prophylactic antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncol

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Rational selection of patients for antibacterial prophylaxis after chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Management of febrile neutropenia: ESMO Clinical Practice Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Antimicrobial stewardship programs in health care systems

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

An antimicrobial stewardship program improves antimicrobial treatment by culture site and the quality of antimicrobial prescribing in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Antibiotic stewardship in the intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Impact of an antimicrobial stewardship programme on patient safety in Singapore General Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Implementation and outcomes of a hospital-wide computerised antimicrobial stewardship programme in a large medical centre in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Implementation of practice guidelines for antifungal therapy in a surgical intensive care unit and its impact on use and costs.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Antibiotic resistance spread in food.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Prevalence and characterization of antibiotic resistant Enterococcus faecalis in French cheeses

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Occasional notes. Please don't eat the salads

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Characterization of Escherichia coli isolates from healthy food handlers in hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Questioning the role of a neutropenic diet following hematopoetic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Neutropenic diet--good practice or myth?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Multidrug resistant commensal Escherichia coli in animals and its impact for public health

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

High prevalence of extended-spectrum-β-lactamase-producing Enterobacteriaceae in organic and conventional retail chicken meat, Germany.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Effect of daily chlorhexidine bathing on hospital-acquired infection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Impact of chlorhexidine-impregnated washcloths on reducing incidence of vancomycin-resistant enterococci colonization in hematology-oncology patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Targeted versus universal decolonization to prevent ICU infection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

The effectiveness of routine daily chlorhexidine gluconate bathing in reducing Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae skin burden among long-term acute care hospital patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Screening and decolonization: does methicillin-susceptible Staphylococcus aureus hold lessons for methicillin-resistant S. aureus?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Association between mucositis severity and vancomycin-resistant enterococcal bloodstream infection in hospitalized cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970344-4

7 January 2021

10.1016/S1470-2045(14)70344-4

Identifiers

DOI

1 reference

1 September 2017

1 reference